Evidence-Based Complementary and Alternative Medicine / 2023 / Article / Tab 7 / Research Article
Effect of Proprietary Chinese Medicine on Coronary Microvascular Dysfunction in Patients with Microvascular Angina: A Systematic Review and Meta-Analysis Table 7 Subgroup analysis of NO based-on dosage form, drug, sample size, treatment duration, sex ratio, average age, location, and year.
Items Subgroup n SMD (95% CI) I 2 (%)z Dosage form Pill 3 1.11 (0.47, 1.76) 78.4 3.373 0.001 Dropping pill 1 0.81 (0.42, 1.21) — 4.017 <0.001 Capsule 7 1.42 (0.95, 1.90) 82.9 5.900 <0.001 Drug YXLC 3 1.03 (0.55, 1.51) 52.2 4.232 <0.001 SBP 2 1.15 (0.05, 2.24) 89.2 2.052 0.040 YXSC 2 1.18 (0.89, 1.46) 0.0 7.984 <0.001 Sample size ≥80 4 1.16 (0.87, 1.45) 45.4 7.872 <0.001 <80 7 1.35 (0.78, 1.98) 86.4 4.611 <0.001 Treatment duration ≥6 months 3 1.05 (0.77, 1.33) 21.4 7.267 <0.001 <6 months 8 1.39 (0.90, 1.87) 84.7 5.626 <0.001 Sex ratio F/M ≥ 100% 9 1.37 (0.97, 1.76) 81.7 6.756 <0.001 F/M < 100% 2 0.89 (0.32, 1.46) 64.7 3.068 0.002 Average age >60 4 1.67 (0.87, 2.48) 91.3 4.062 <0.001 <60 7 1.07 (0.79, 1.35) 49.5 7.510 <0.001 Location North 7 1.39 (0.89, 1.89) 86.1 5.407 <0.001 South 4 1.10 (0.73, 1.48) 51.2 5.819 <0.001 Year 2016 2 0.65 (0.30, 1.00) 0.0 3.655 <0.001 2018 2 1.53 (1.16, 1.90) 0.0 8.042 <0.001 2019 2 1.12 (0.77, 1.47) 0.0 6.295 <0.001